Patent · US Active

Hybrid caulimovirus promoters and constructs thereof

US8987434B2 · kind B2 · utility

0Cited by
21References
24Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 5, 2013
Grant dateMar 24, 2015
Priority date
Expiry dateJun 5, 2033

Classification

  • Technology area (CPC Y)Emerging Cross-Sectional Technologies
  • CPC primaryY02A40/146
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

The present invention relates to novel hybrid promoters comprising a caulimovirus promoter operably linked to one or more of an EF1α, Act8, Act2 or Act11 promoter. The present invention also relates to novel DNA constructs comprising at least one expression cassette which comprises the hybrid promoter thereof. The present invention further relates to transgenic plants/seeds comprising such DNA constructs.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.